Radiation Therapy in Lung Tumors: Recent Trends and Current Issues
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 21 March 2026 | Viewed by 6
Special Issue Editors
Interests: lung cancer; radiation oncology; combined treatment; brain metastases; benign disease
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Radiation therapy still plays an important role in the management of patients suffering from lung tumors, with a series of breakthroughs in recent decades leading to major improvements in the outcome of patients. This is partially due to technical developments but also a better understanding of the disease and integration within a multimodal approach including surgery, chemotherapy and, more recently, immunotherapy. Another major component is certainly the many imaging modalities, including CT but mainly PET-CT, not only for the evaluation of the disease but also directly for radiotherapy planning. In the current issue, we are planning to present the current situation but also to outline future directions and paths to explore.
Prof. Dr. Paul Jules van Houtte
Prof. Dr. Sara Ramella
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lung cancer
- immunotherapy
- chemotherapy
- PET-CT
- surgery
- oligo-metastases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
